A gene-editing therapy for sickle cell disease was approved by US regulators, a milestone for the DNA-modifying technology Crispr. Crispr Co-Inventor, 2020 Nobel Prize winner in chemistry, and Innovative Genomics Institute founder Jennifer Doudna joins Caroline Hyde and Ed Ludlow on "Bloomberg Technology."
--------
Like this video? Subscribe to Bloomberg Technology on YouTube:
   / @bloombergtechnology  
Watch the latest full episodes of "Bloomberg Technology" with Caroline Hyde and Ed Ludlow here: https://tinyurl.com/ycyevxda

Get the latest in tech from Silicon Valley and around the world here:
https://www.bloomberg.com/technology

Connect with us on...
Twitter:   / technology  
Facebook:   / bloombergtechnology  
Instagram:   / bloombergbusiness